Inhibition of GPC-1 was reported to impair cellular responses to growth factors such as FGF2, EGF and HGF in PANC-1 (pancreatic carcinoma) cells and decrease tumor formation in nude mice10. The gene discussed is GPC1; the disease is neoplasm.